Dossier
clinicaltrials
observational
Study of Pregnancy in Patients With Myeloproliferative Neoplasms
Key claim: A study is measuring live-birth rates in pregnant patients with myeloproliferative neoplasms managed under a risk-adapted clinical algorithm.
Abstract
This is a study to evaluate pregnancy in patients with myeloproliferative neoplasms. The main endpoint of this study is to determine the number of live births in pregnant MPN patients who are managed by a risk-adapted algorithm
Why this matters
A study is measuring live-birth rates in pregnant patients with myeloproliferative neoplasms managed under a risk-adapted clinical algorithm.